Table 1.
Main results from trials on Escherichia coli Nissle on ulcerative colitis
Efficacy of EcN 1917 in maintanance of UC remission |
Results from major randomized controlled clinical trials |
EcN 200 mg/d is equivalent to Mesalazine 1000 mg/d in mantainance of UC remission[27] |
EcN 400 mg/d is equivalent to to Mesalazine 2400 mg/d in maintanance of UC remission following an acute flare[28] |
EcN 200 mg/d is equivalent to Mesalazine 1500 mg/d in mantainance of UC remission[10] |
Results from minor studies |
Rectal admistration of EcN 40 mL/d is effective in moderate distal active UC[30] |
EcN 200 mg/d is equivalent to Mesalazine 1500 mg/d in maintanance of UC remission[6] |
EcN: Escherichia coli Nissle; UC: Ulcerative colitis.